发明名称 |
New compounds |
摘要 |
<p>The present invention provides new organic compounds that are useful in the treatment of conditions or disorders associated with DGAT1 activity, particularly type 2 diabetes, and pharmaceutical compositions and combinations comprising such compounds.</p> |
申请公布号 |
EP2404905(A1) |
申请公布日期 |
2012.01.11 |
申请号 |
EP20110158212 |
申请日期 |
2007.03.28 |
申请人 |
NOVARTIS AG |
发明人 |
SERRANO-WU, MICHAEL H;KWAK, YOUNG-SHIN;LIU, WENMING |
分类号 |
C07D213/74;A61K31/421;A61K31/426;A61K31/44;A61K31/4427;A61K31/4965;A61K31/50;A61K31/53;C07D213/75;C07D213/81;C07D213/82;C07D237/20;C07D239/42;C07D263/48;C07D277/42;C07D401/10;C07D401/12;C07D401/14;C07D405/12;C07D413/10;C07D413/12 |
主分类号 |
C07D213/74 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|